Fig 1.
Schematic figure of the study protocol.
Arrows represent NB-UVB treatment sessions.
Table 1.
Patients’ demographic data and NB-UVB treatment outcomes.
Fig 2.
Relative S100A8 gene expression in lesional and non-lesional skin of patients with psoriasis before and after NB-UVB treatment.
n = 27, ● = lesional skin, ■ = non-lesional skin. (*** p<0.001).
Fig 3.
Relative gene expression of S100A9 in lesional and non-lesional skin of patients with psoriasis before and after NB-UVB treatment.
n = 27, ● = lesional skin, ■ = non-lesional skin. (*** p<0.001).
Fig 4.
Skin protein levels of S100A8/A9 heterocomplex in lesional and non-lesional skin of patients with psoriasis before and after NB-UVB treatment.
n = 27, ● = lesional skin, ■ = non-lesional skin. (*** p<0.001).
Fig 5.
Serum S100A8/A9 levels before and after completion of NB-UVB psoriasis treatment.
No significant difference was found (n = 27).
Fig 6.
Psoriasis severity (PASI) and serum S100A8/A9 protein levels before, during and after NB-UVB treatment.
No correlation was found between PASI and serum S100A8/A9 protein.
Fig 7.
S100A8/A9 protein in lesional skin after NB-UVB and target lesion PASI.
A moderate correlation was found.